Conmed (CNMD) Tops Q3 EPS by 6c; Raises Outlook
Conmed (NASDAQ: CNMD) reported Q3 EPS of $0.62, $0.06 better than the ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
